Here's Why Rigel Pharmaceuticals Stock Jumped as Much as 10.7% Today [The Motley Fool]
Rigel Pharmaceuticals, Inc. (RIGL)
Last rigel pharmaceuticals, inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.rigel.com
Company Research
Source: The Motley Fool
Here's Why Rigel Pharmaceuticals Stock Jumped as Much as 10.7% Today What happened Shares of Rigel Pharmaceuticals ( NASDAQ:RIGL Yahoo! Finance But it's close enough, and somewhat eases concerns over the drug's sluggish launch. Perhaps more important, Rigel announced that its pipeline -- another concern -- is suddenly buzzing with activity. The company completed a phase trial for its lead wholly owned drug candidate and announced an entirely new branch of its pipeline that had never before been known to investors. The first drug candidate from this new focus has already started a phase clinical trial. As of :0 p.m. EDT on Wednesday, the stock had settled to a 7.7% gain. Image source: Getty Images. So what Rigel fell out of favor with investors The recent update provides some hope that Tavalisse is getting back on track. The unofficial $.7 million figure would translate to a % quarter-over-quarter increase, up from recent 0% sequential growth clips. The update also shows that Rigel P
Show less
Read more
Impact Snapshot
Event Time:
RIGL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RIGL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RIGL alerts
High impacting Rigel Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
RIGL
News
- Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its price target raised by analysts at Cantor Fitzgerald from $15.00 to $25.00. They now have a "neutral" rating on the stock.MarketBeat
- Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $57.00 price target on the stock.MarketBeat
- Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition [Yahoo! Finance]Yahoo! Finance
- Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and ExpositionPR Newswire
- Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its price target raised by analysts at B. Riley from $17.00 to $27.00. They now have a "neutral" rating on the stock.MarketBeat
RIGL
Earnings
- 11/7/24 - Beat
RIGL
Sec Filings
- 12/9/24 - Form 8-K
- 11/26/24 - Form 4
- 11/26/24 - Form 4
- RIGL's page on the SEC website